Upstart shares drop as it announces $500 million convertible notes offering, even after posting strong Q2 results and raising ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

A 40-year-old woman recently learned she does not qualify for Social Security Disability Insurance benefits, despite having a ...

BigBear.ai shares are trading marginally lower Monday morning. Investors await the company's Q2 financial results.

Commodities In commodity news, oil traded up 0.5% to $64.19 while gold traded down 2.3% at $3,408.70. Silver traded down 1.5% ...

The Bear Cave investigative financial newsletter warned of widespread pump-and-dump scams coordinated via WhatsApp groups.

Analyst predicts potential turnaround for Under Armour in long term, but cites near-term challenges like tariffs and ...

A simple 3-step system helped identify breakout trades like DAVE (87%), MP (45%), and OUST (56%), before they moved. Join us ...

Analysts estimate that Ondas Holdings will report an earnings per share (EPS) of $-0.08. Anticipation surrounds Ondas Holdings's announcement, with investors hoping to hear about both surpassing ...

Analysts estimate that NeoGenomics will report an earnings per share (EPS) of $-0.01. Anticipation surrounds NeoGenomics's announcement, with investors hoping to hear about both surpassing estimates ...

Analysts have given Stoke Therapeutics a total of 3 ratings, with the consensus rating being Buy. The average one-year price target is $29.0, indicating a potential 121.37% upside.

Return on Equity (ROE): Taysha Gene Therapies's ROE lags behind industry averages, suggesting challenges in maximizing ...